1. Amundsen, S. et al., (2015). Pharmacological treatment of a migraine during pregnancy and breastfeeding. Nature Reviews Neurology, 29, Available at: https://www.researchgate.net/profile/Kateina_Nezvalova-Henriksen/publication/273703247_Pharmacological_treatment_of_migraine_during_pregnancy_and_breastfeeding/links/550bdfec0cf2855640975a29.pdf.
2. Andrade, C., (2016). Use of acetaminophen (paracetamol) during pregnancy and the risk of autism spectrum disorder in the offspring. Medical News Today, February. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26930528 [Accessed 15 March 2017].
3. Avella-Garcia, C.B. et al., (2016). Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. International Journal of Epidemiology, 0(0), pp.1-9. Available at: https://www.researchgate.net/profile/Jordi_Julvez/publication/304577447_Acetaminophen_use_in_pregnancy_and_neurodevelopment_attention_function_and_autism_spectrum_symptoms/links/577cf78508aec3b74337ec65.pdf.
4. Bauer, A.Z. and Kriebel, D., (2013). Prenatal and perinatal analgesic exposure and autism: an ecological link. Environmental Health, 12(41), Available at: https://ehjournal.biomedcentral.com/articles/10.1186/1476-069X-12-41.
5. Bienkowski, B., (2016). Acetaminophen during pregnancy linked to autism. Environmental Health News, 6 July. Available at: http://www.environmentalhealthnews.org/ehs/news/2016/july/acetaminophen-during-pregnancy-linked-to-autism.
6. Blecharz-Klin, K. et al., (2015). Developmental exposure to paracetamol causes biochemical alterations in the medulla oblongata. Environmental toxicology and pharmacology, 40(2), pp.369-74. Available at: http://europepmc.org/abstract/med/26233562.
7. Brandlistuen, R.E. et al., (2013). Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. International journal of epidemiology, 42(6), pp.1702-13. Available at: https://academic.oup.com/ije/article/42/6/1702/739709/Prenatal-paracetamol-exposure-and-child.
8. Bulman, M., (2016). The link between paracetamol and autism dismissed by scientists. Independent, 2 July. Available at: http://www.independent.co.uk/life-style/health-and-families/health-news/paracetamol-autism-link-dismissed-scientists-a7115411.html.
9. Dardennesa, R.M. et al., (2011). Treating the cause of illness rather than the symptoms: Parental causal beliefs and treatment choices in autism spectrum disorder. Research in developmental disabilities, 32(3), pp.1137-46. Available at: http://www.sciencedirect.com/science/article/pii/S0891422211000114.
10. De Santis, M. et al., (2004). The risk of drug-induced congenital defects. Journal of Obstetrics & Gynecology and Reproductive Biology, 117(1), pp.10-19. Available at: http://www.ejog.org/article/S0301-2115(04)00245-3/abstract.
11. Dietert, R.R., Dietert, J.M. and DeWitt, J.C., (2011). Environmental risk factors for autism. Emerging health threats journal, 4, Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168222/.
12. ESHRE Capri Workshop Group, (2014). Birth defects and congenital health risks in children conceived through assisted reproduction technology (ART): A meeting report. 31(8), pp.947-58. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130939/.
13. Guttuso, T., Shaman, M. and Thornburg, L.L., (2014). The potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy. European Journal of Obstetrics & Gynaecology and Reproductive Biology, 181, pp.280-83. Available at: https://www.researchgate.net/publication/265392709_Potential_maternal_symptomatic_benefit_of_gabapentin_and_review_of_its_safety_in_pregnancy.
14. Källén, B., Borg, N. and Reis, M., (2013). The use of central nervous system active drugs during pregnancy. Pharmaceuticals, 6(10), pp.1221-86. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24275849/.
15. Liew, Z., Ritz, B., Virk, J. and Olsen, J., (2015). Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study. Autism Research, Available at: http://europepmc.org/abstract/med/26688372.
16. Macrae, F. and Hagan, P., (2016). One paracetamol in pregnancy could raise the risk of autism. New Zealand Herald, 2 July. Available at: http://www.nzherald.co.nz/lifestyle/news/article.cfm?c_id=6&objectid=11667634.
17. Moody, O., (2016). Paracetamol during pregnancy linked to autism. The Times, 2 July. Available at: http://www.thetimes.co.uk/article/paracetamol-during-pregnancy-linked-to-autism-7kl5twsxk.
18. Ornoy, A., Weinstein-Fudim, L. and Ergaz, Z., (2016). Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD). Frontiers in Neuroscience, 10(316), Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933715/.
19. Pickles, K., (2016). Women who take paracetamol during pregnancy ‘risk having a child with autism or ADHD’. Daily Mail, 1 July. Available at: http://www.dailymail.co.uk/health/article-3669657/Women-paracetamol-pregnancy-risk-having-child-autism-ADHD.html [Accessed 15 March 2017].
20. Prandota, J., (2011). Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis. Research in Autism Spectrum Disorders, 5(1), pp.14-59. Available at: http://www.sciencedirect.com/science/article/pii/S1750946710000450.
21. Rusu, C., Preda, C., Sireteanu, A. and Vulpoi, C., (2015). Risk Factors In Autism Spectrum Disorders: The Role Of Genetic, Epigenetic, Immune And Environmental Interactions. Environmental Engineering & Management Journal (EEMJ), 14(4), pp.901-17. Available at: http://omicron.ch.tuiasi.ro/EEMJ/pdfs/vol14/no4/22_769_Rusu_13.pdf.
22. Schaefer, C. et al., (2008). Using observational cohort data for studying drug effects on pregnancy outcome—methodological considerations. Reproductive Toxicology, 26(1), pp.36–41. Available at: http://s3.amazonaws.com/academia.edu.documents/46637156/j.reprotox.2008.05.06420160620-26487-1j3nnlm.pdf?AWSAccessKeyId=AKIAIWOWYYGZ2Y53UL3A&Expires=1489709159&Signature=O876A4mugNDIkM1Xv%2BcoUh6FZiA%3D&response-content-disposition=inline%3B%20filename%3D.
23. Schaefer, C., Peters, P.W. and Miller, R.K., (2007). Drugs during pregnancy and lactation: treatment options and risk assessment. 1st ed. London: Academic Press. Available at: http://pharmacy.frigoplus.co.rs/wp-content/uploads/2015/04/Drugs-During-Pregnancy-and-Lactation-2nd-Edition-Treatment-Options-and-Risk-Assessment.pdf.
24. Shaw, W., (2013). Evidence that increased acetaminophen use in genetically vulnerable children appears to be a major cause of the epidemics of autism, attention deficit with hyperactivity, and asthma. Journal of restorative medicine, 2(1), pp.14-29. Available at: http://www.ingentaconnect.com/content/aarm/jrm/2013/00000002/00000001/art00003.
25. Sivojelezova, A. et al., (2005). Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. American journal of obstetrics and gynaecology, 193(26), pp.2004-09. Available at: http://www.ajog.org/article/S0002-9378(05)00656-3/abstract.
26. Thomas, R., (2016). Paracetamol during pregnancy associated with autism in boys. Pharmacy Magazine., 8 August. Available at: http://www.pharmacymagazine.co.uk/paracetamol-during-pregnancy-associated-with-autism-in-boys.
27. Whiteman, H., (2016). Acetaminophen use in pregnancy linked to autism, ADHD in offspring. [Online] Available at: http://www.medicalnewstoday.com/articles/311418.php [Accessed 2017 March 2017].
The download will start shortly.